Industry landscapes
The companies, capital and talent shaping healthtech in Los Angeles. Find the leaders. Understand the segments. See where the activity is.
An industry ecosystem,
measured in context.
24 featured companies from the funding, hiring, revenue and team-size leaderboards.
Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗
No company example met every recorded classification, independence and public-profile gate in this snapshot. The live directory may have newer qualifying companies.
Explore classified startups in Radar ↗A few useful ratios bring the size of this ecosystem into perspective.
42 of 602 tracked companies have open roles.
142 of 602 tracked companies have a recorded round.
Share of disclosed capital received by the three largest recorded recipients.
Midpoint of 230 rounds with a disclosed amount.
Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 42.4% of disclosed capital, while 76.4% of tracked companies have no recorded funding round.
Explore the segments →Recorded company formation and disclosed funding across the complete annual series shown.
Sum of recorded funding rounds · USD
| Year | Funding (USD) | Founded | Raising |
|---|---|---|---|
| 2016 | $213.27M | 61 | 22 |
| 2017 | $62.46M | 32 | 18 |
| 2018 | $105.46M | 39 | 16 |
| 2019 | $58.82M | 41 | 19 |
| 2020 | $131.22M | 53 | 17 |
| 2021 | $817.58M | 48 | 25 |
| 2022 | $471.37M | 29 | 28 |
| 2023 | $98.49M | 15 | 21 |
| 2024 | $150.08M | 12 | 18 |
| 2025 | $200.27M | 4 | 15 |
Share of all disclosed company funding.
270 recorded rounds since 2016
Recorded participation in healthtech company rounds since 2016.
Backed by Wing2Wingfoundation and National Science Foundation and others.
Backed by Catcher Technology.
Backed by .
Backed by North Castle Partners and Rx3 Growth Partners.
Participating investors were not recorded in this snapshot.
Backed by SoftBank Vision Fund and Yiheng Capital and others.
Backed by Oak HC/FT and GrECo Group and others.
Backed by Oak HC/FT and Cedars Sinai Health Ventures and others.
Backed by Renaissance Acquisition Holdings and Delta Dental.
Backed by Walgreens Boots Alliance and Anthem and others.
Backed by General Catalyst and Khosla Ventures and others.
Backed by Transformation Capital.
Participating investors were not recorded in this snapshot.
Annual accounts for reporting companies linked to this landscape, on like-for-like currency and reporting bases.
Display conversions use the dated reference rates above. Where a verified rate is unavailable, figures retain their source currency. Each reporting cohort keeps its currency and accounting basis separate.
FY2025 · company accounts; aggregate reporting threshold not met · 2 reporting entities from 4 eligible matches.
Sum of reporting-entity revenue; not Los Angeles market sales.
Combined result for the same cohort.
Combined net income ÷ combined revenue.
The middle covered reporting entity.
None of 2 covered entities.
Share of covered revenue from the five largest entities.
Reported cohort totals by year; coverage is stated for every period.
Bar height shows revenue. Changes in coverage can affect totals.
FY2025 · 2 reporting entities
Up to eight fixed company previews show financial amounts. Search and sort the wider company list, then continue in Radar.
| Company / reporting entity | Revenue | Net profit / loss | Net margin | Revenue growth | Total assets |
|---|---|---|---|---|---|
| Consensus ↗1866633 | $349.7m | $84.5m | +24.2% | — | — |
| MannKind Corp ↗899460 | $349.0m | $5.9m | +1.7% | — | — |
Explore full company accounts and filings.
Choose “View accounts” to inspect an available company preview.
Each pair uses the same year, currency and reporting basis. Cohort overlap is disclosed.
| Industry | Covered / eligible | Revenue total | Median revenue | Net profit / loss | Aggregate margin | Profitable share | Overlap |
|---|
Available-account cohorts are not estimates of whole industries. Overlapping entities can occur in more than one cohort; do not add cohort totals.
Filed annual accounts for exact designated national identifiers. Every aggregate and peer pair uses one fiscal year, source currency and reporting basis; periods, coverage and overlap are explicit; 2026 partials are excluded.
The same up to eight reporting entities remain open across years, filters and sorts. Other company figures are available in Radar.
Source currencies and accounting bases stay separate. Missing accounts are excluded rather than treated as zero. Exact reporting periods appear on company previews. Annual totals can change with coverage and do not measure growth of a fixed company cohort.
How the Los Angeles companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.
11 of the 602 companies on this page carry a measured traffic record (1.8%); these are the largest of those, by monthly visits. The median among them is 481,766 visits.
| Company | Monthly visits | Authority | Mobile |
|---|---|---|---|
| IHerbiherb.com | 34,128,286 | 77 | 66.5% |
| Rularula.com | 2,517,017 | 44 | 67.5% |
| Eat This Mucheatthismuch.com | 1,847,750 | 70 | 58.2% |
| Safe Ride Healthsaferidehealth.com | 770,440 | 37 | 71.2% |
| iRestore Laser Hair Growth Systemirestorelaser.com | 536,099 | 38 | 81% |
| Sketchysketchy.com | 481,766 | 45 | 8.4% |
| Leafwellleafwell.com | 419,085 | 48 | 79.5% |
| arketaarketa.co | 306,414 | 25 | 57.8% |
| [P]Rehabtheprehabguys.com | 243,148 | 38 | 54.4% |
| Waking Upwakingup.com | 231,095 | 39 | 38.7% |
Visits and authority are third-party web estimates, not company-reported figures.
69 of these companies (11.5%) publish at least one Android app — 88 apps in all, carrying 69.4M installs between them.
| App | Installs | Rating | Store category |
|---|---|---|---|
| iHerb: Vitamins & SupplementsIHerb | 35.8M | 4.7 | Shopping |
| Period TrackerGP Apps | 24.2M | 4.4 | Health & Fitness |
| Telehealth by SimplePracticeSimplePractice | 2.8M | 4.5 | Medical |
| Eat This Much - Meal PlannerEat This Much | 2.6M | 4.7 | Health & Fitness |
| Waking Up: Meditation & WisdomWaking Up | 2.1M | 4.6 | Health & Fitness |
| TherabodyTherabody | 543.5K | 4.8 | Health & Fitness |
| Period Tracker DeluxeGP Apps | 264.1K | 4.5 | Health & Fitness |
| SimplePractice for CliniciansSimplePractice | 135.4K | 3.6 | Medical |
| PowerDotTherabody | 112K | 4.4 | Health & Fitness |
| MySafeRide - Manage your ridesSafe Ride Health | 94K | 3.7 | Medical |
Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.
The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q4–2026Q2).
| Segment | Apps | Installs | Leading app | Release trend |
|---|---|---|---|---|
| Healthcare Booking Platforms | 13 | 35.9M | iHerb: Vitamins & Supplements 35.8M | |
| Disease Self Management | 35 | 30.4M | Period Tracker 24.2M | |
| Fitness & Wellness Tech | 13 | 4.9M | Eat This Much - Meal Planner 2.6M | |
| Healthcare It | 37 | 3.2M | Telehealth by SimplePractice 2.8M | |
| Wearable Technology | 8 | 213.9K | 얼마야 – 가품없는 중고 명품 직거래 장터, 즉시매입, 58.7K | |
| Online Mom & Baby Care | 5 | 170.7K | MIKU 70.6K | |
| Hrtech | 5 | 54.1K | CareRev 45.2K | |
| Employee Health It | 3 | 35.8K | United We Care: Mental Health 35.6K |
A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.
New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.
Darker bars are new releases, lighter bars apps updated. 87 of 88 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.
Explore the segments behind the headline numbers.
Rank segments by scale, hiring or disclosed funding.
Companies can sit in several segments. Counts and funding overlap.
The largest measured segment in this report snapshot.
23 companies hiring · $3.41B disclosed funding
Explore in RadarCommon revenue models; a company can use more than one.
Recorded corporate activity linked to companies in this landscape.
ANEUVO, a medical device startup developing neuromodulation implants for spinal cord injury, announced a $22 million Series C to accelerate clinical development of its implantable therapy.
These acquisitions include Jefferson Soul, a cultivation and extraction company with established regional brands in California's Emerald Triangle region, where the company maintains a website at www.jefferson-soul.com.
Tech-enabled health care staffing platform IntelyCare has acquired CareRev, an acute care workforce company.
"This is an exciting and highly complementary acquisition for iHerb," said Emun Zabihi, chief executive officer of iHerb, in a press release.
Standard Dental Labs Inc. today announced that it has signed a binding agreement on November 4th, 2025 to acquire Dream Dentistry Labs, LLC.
MannKind Corporation (Nasdaq: MNKD) successfully completed the previously announced acquisition of scPharmaceuticals Inc.
SprintRay has acquired the EnvisionTec/ETEC portfolio of dental products, following Desktop Metal's bankruptcy.
The Deal Clarity will join mPulse to help advance leadership in their health experience and insights (HXI) category.
CentralReach, a dominant provider of autism and intellectual and developmental disabilities (IDD) care software, has acquired AI-focused companies SpectrumAI and AI Measures.
Rula Healthcare Los Angeles, CA 2019 $90M+
Top 10 categories among 145 recorded events in the 24-month window.
2 companies with recorded IPO activity
Direct Listing1 reports
IPO · Nasdaq6 reports
6 tracked people moves
Appointment Chief Communications Officer
Appointment Chief Network Officer
Appointment Board of Directors Member
Appointment Chief Medical Officer
Products, platforms and features in the recorded window
Sale
1 companies with reported reductions
84 rolesCOVID-19 pandemic
3 tracked suits
Wrongful termination for reporting clinical data issuesCivil · Filed
Shareholder derivative action challenging mergerCivil · Filed
Reported company results in the recorded window.
Median across 22 reported growth observations; companies may contribute multiple periods.
Company-linked deal reports; status is preserved as recorded.
| Acquirer → target | Status | Date | Value / context |
|---|---|---|---|
| thc therapeutics→Kalix ↗ | 2026-03-03 | Not stated in snapshot | |
| intelycare→CareRev ↗ | Completed | 2026-01-22 | Not stated in snapshot |
| IHerb→vitacost | Announced | 2026-01-09 | Not stated in snapshot |
| Standard Dental Labs→Dream Dentistry Labs, LLC | Announced | 2025-11-04 | Not stated in snapshot |
| MannKind Corp→scpharmaceuticals | Completed | 2025-10-07 | Not stated in snapshot |
| SprintRay→envisiontec | Announced | 2025-09-04 | Not stated in snapshot |
A discussion or rumour is not a completed transaction. An unstated value is not zero.
4,647 postings in the preceding 12 months. The full 7,111-posting snapshot covers 67 employers.
131 tracked postings mention remote work.
466 postings specify a level.
Top skills across 7,111 tracked postings in the available jobs snapshot.
Median across 229 postings with pay data, expressed in USD.
| Company | Employees |
|---|---|
| Pacific Dental Services ↗ | 12,260 |
| Freudenberg Medical ↗ | 680 |
| SimplePractice ↗ | 435 |
| Stability Healthcare ↗ | 412 |
| MannKind Corp ↗ | 322 |
| Life Alert ↗ | 304 |
| mPulse ↗ | 120 |
| Rula ↗ | 104 |
361 founders and chief executives across 270 companies.
Mannkind, ex-Amgen, ex-Bristol Myers Squibb, Massachusetts College of Pharmacy and Health Sciences, 2014
UCLA BA, Chapman University MHA
Ex-j2 Global, DLJDLJ.
Omninet Capital, ex-Theragun, USC Gould School of Law, 1970
Ex-Founder Nano Precision Medical. University of California, Berkeley PhD 2011
Ex-Techtronic Industries, Daetum Design. Swinburne University of Technology BA 2008, Savannah College of Art and Design MA 2013
Akido Labs, ex-Medical Device Development Facility At Usc, ex-National Collegiate Inventors And Innovators Alliance…
Founder Tixwise, ex-Bink Financial Innovation, Israeli Air Force. The Open University of Israel BSc 2010
Shanghai Jiao Tong University BA
Ex-Applied Predictive Technologies. Massachusetts Institute of Technology BS 2010, Stanford University MS 2016
Ex-Cleerly. Rutgers University BA 1995, The LBJ School of Public Affairs 1999
Adastral Funds, ex-Cycle House, ex-Visalus, IAE Business School, 2010
76 profiles with education records.
9 profiles with prior-work records.
Profiles cover recorded founders and leaders; contact details remain in Radar.
56,863 articles in the measured 12-month window.
Healthtech coverage tagged Los Angeles · articles per complete quarter
| Quarter | Articles |
|---|---|
| 2021Q2 | 9,912 |
| 2021Q3 | 10,937 |
| 2021Q4 | 9,542 |
| 2022Q1 | 11,061 |
| 2022Q2 | 10,911 |
| 2022Q3 | 9,530 |
| 2022Q4 | 9,542 |
| 2023Q1 | 10,870 |
| 2023Q2 | 11,161 |
| 2023Q3 | 10,518 |
| 2023Q4 | 11,018 |
| 2024Q1 | 12,886 |
| 2024Q2 | 12,634 |
| 2024Q3 | 13,273 |
| 2024Q4 | 12,132 |
| 2025Q1 | 21,563 |
| 2025Q2 | 15,378 |
| 2025Q3 | 17,375 |
| 2025Q4 | 12,066 |
| 2026Q1 | 12,169 |
Article volume measures coverage, not market sales.
196 recorded company events across 25 companies; percentages use that event total.
Healthtech coverage tagged Los Angeles · ranked by full-period article count.
Recent and prior counts use the source comparison windows.
United States comparison coverage
| Keyword | Recent | Prior | Change |
|---|---|---|---|
| foreign policy analysis | 7,248 | 4,848 | 50% |
| multilateral diplomacy | 7,093 | 4,378 | 62% |
| national security strategy | 7,075 | 3,119 | 127% |
| bilateral trade | 5,915 | 4,221 | 40% |
| diplomatic engagements | 5,572 | 3,522 | 58% |
| vaccine candidates | 5,445 | 1,402 | 288% |
| vaccine trials | 4,931 | 1,374 | 259% |
| vaccination campaigns | 4,914 | 1,021 | 381% |
| countries | 4,204 | 1,897 | 122% |
| vaccine immunogenicity | 4,034 | 1,074 | 276% |
| olympic team selections | 1,407 | 2,836 | -50% |
| olympic trials | 1,103 | 2,360 | -53% |
| ceasefire violations | 903 | 1,703 | -47% |
| summer olympics athletics | 209 | 1,564 | -87% |
| electioneering tactics | 665 | 1,562 | -57% |
United States comparison coverage
territories, disputed islands, vaccine mandate compliance
42.5% critical · 22.3% positivepublic health funding, investment deal, inflation reports fx
46.9% critical · 41.2% positiveearnings report, quarterly results, quarterly financials
35.3% critical · 45.4% positiveHealthtech coverage tagged Los Angeles. Topic labels describe recorded classifications and can include broad context.
8,843 papers in the recorded india scope.
Tone counts: 7,674 positive · 337 neutral · 832 negative.
Landmark: Implementation strategies: recommendations for specifying and reporting
Landmark: Realist synthesis: illustrating the method for implementation research
Landmark: Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science
Common problems researchers identify · 0118.0% of this theme group
Drug discovery (305) · Drug (169) · Pharmacogenomics (141) · Drug development (96)
Cancer epigenetics drug discovery and development: the challenge of hitting the mark
Proof of Concept: Network and Systems Biology Approaches Aid in the Discovery of Potent Anticancer Drug Combinations
| Year | Share index |
|---|---|
| 2022 | 155.8 |
| 2023 | 160.7 |
| 2024 | 168.0 |
| 2025 | 209.7 |
Common problems researchers identify · 0218.0% of this theme group
Telemedicine (687) · Telehealth (648) · Health care (347) · Nursing (98)
Ensuring full participation of people with disabilities in an era of telehealth
Strategies for Evaluating Telehealth
| Year | Share index |
|---|---|
| 2022 | 541.2 |
| 2023 | 553.5 |
| 2024 | 538.6 |
| 2025 | 840.0 |
Common problems researchers identify · 0313.6% of this theme group
Health administration (209) · Nursing research (154) · Health informatics (234) · Public health (215)
Is Europe putting theory into practice? A qualitative study of the level of self-management support in chronic care management approaches
Understanding integrated service delivery: a scoping review of models for noncommunicable disease and mental health interventions in low-and
| Year | Share index |
|---|---|
| 2022 | 22.0 |
| 2023 | 20.3 |
| 2024 | 26.9 |
| 2025 | 43.6 |
Common problems researchers identify · 0413.6% of this theme group
Precision medicine (602) · Personalized medicine (282) · Cancer (105) · Disease (121)
The growing role of precision and personalized medicine for cancer treatment
Precision Medicine: Disease Subtyping and Tailored Treatment
| Year | Share index |
|---|---|
| 2022 | 764.3 |
| 2023 | 1049.9 |
| 2024 | 798.6 |
| 2025 | 777.4 |
Common problems researchers identify · 0513.5% of this theme group
Digital health (431) · Health care (328) · Health informatics (149) · Informatics (73)
Technology and Universal Health Coverage: Examining the role of digital health
Digital Health and Health Systems of the Future
| Year | Share index |
|---|---|
| 2022 | 540.1 |
| 2023 | 553.1 |
| 2024 | 540.7 |
| 2025 | 849.1 |
Common problems researchers identify · 0613.1% of this theme group
Pandemic (570) · Coronavirus disease 2019 (384) · 2019-20 coronavirus outbreak (108) · Telemedicine (386)
Telemedicine and health access inequalities during the COVID-19 pandemic
Examining telehealth use among primary care patients, providers, and clinics during the COVID-19 pandemic
| Year | Share index |
|---|---|
| 2022 | 661.4 |
| 2023 | 443.9 |
| 2024 | 330.0 |
| 2025 | 212.6 |
Common problems researchers identify · 0710.3% of this theme group
Medical device (152) · Wearable computer (47) · Health care (152) · Food and drug administration (36)
The Need to Apply Medical Device Informatics in Developing Standards for Safe Interoperable Medical Systems
Medical Device Usability Analyses
| Year | Share index |
|---|---|
| 2022 | 564.5 |
| 2023 | 577.8 |
| 2024 | 564.0 |
| 2025 | 876.1 |
Cautions · 0124.5% of this theme group
Telemedicine (394) · Telehealth (307) · Medical emergency (63) · Health care (134)
Home telehealth for chronic disease management: A systematic review and an analysis of economic evaluations
Transition to telehealth
| Year | Share index |
|---|---|
| 2022 | 215.3 |
| 2023 | 197.2 |
| 2024 | 209.5 |
| 2025 | 199.0 |
Cautions · 0215.8% of this theme group
Health informatics (124) · Health administration (73) · Nursing research (49) · Health care (117)
A systematic approach to the planning, implementation, monitoring, and evaluation of integrated health services
INFORMATION SYSTEMS IN HEALTH MANAGEMENT: INNOVATIONS AND CHALLENGES IN THE DIGITAL ERA
| Year | Share index |
|---|---|
| 2022 | 22.0 |
| 2023 | 20.3 |
| 2024 | 26.9 |
| 2025 | 43.6 |
Cautions · 0315.4% of this theme group
Pandemic (268) · Coronavirus disease 2019 (208) · Telemedicine (212) · Telehealth (177)
Patient Perception of Telehealth Services for Breast and Gynecologic Oncology Care during the COVID-19 Pandemic: A Single Center Survey-base
Community Mental Health Clinicians’ Perspectives on Telehealth During the COVID-19 Pandemic: Mixed Methods Study
| Year | Share index |
|---|---|
| 2022 | 548.5 |
| 2023 | 379.1 |
| 2024 | 244.3 |
| 2025 | 190.4 |
Cautions · 0414.4% of this theme group
Pharmacogenomics (86) · Drug discovery (91) · Drug (59) · Pharmacology (33)
Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and <scp>Meta‐Analysis</scp> of Prospective, Controlled Clinic
Warfarin Pharmacogenomics in Diverse Populations
| Year | Share index |
|---|---|
| 2022 | 155.8 |
| 2023 | 160.7 |
| 2024 | 168.0 |
| 2025 | 209.7 |
Cautions · 0511.4% of this theme group
Psychological intervention (118) · Digital health (104) · Mental health (62) · Intervention (56)
Digital Health Interventions to Enhance Prevention in Primary Care: Scoping Review
Digitization and its Discontents: The Promise and Limitations of Digital Mental Health Interventions
| Year | Share index |
|---|---|
| 2022 | 784.7 |
| 2023 | 800.0 |
| 2024 | 802.5 |
| 2025 | 1143.3 |
Cautions · 0611.3% of this theme group
Precision medicine (127) · Personalized medicine (61) · Cancer (49) · Oncology (37)
Impact of Precision Medicine in Diverse Cancers: A Meta-Analysis of Phase II Clinical Trials
Mechanism-Centric Approaches for Biomarker Detection and Precision Therapeutics in Cancer
| Year | Share index |
|---|---|
| 2022 | 764.3 |
| 2023 | 1049.9 |
| 2024 | 798.6 |
| 2025 | 777.4 |
Cautions · 077.1% of this theme group
Applications of artificial intelligence (19) · Health care (53) · Precision medicine (36) · Personalized medicine (28)
Leveraging Artificial Intelligence for Predictive Healthcare: A Data-Driven Approach to Early Diagnosis and Personalized Treatment
Advancements in the treatment of autoimmune diseases: Integrating artificial intelligence for personalized medicine
| Year | Share index |
|---|---|
| 2022 | 543.5 |
| 2023 | 558.4 |
| 2024 | 545.5 |
| 2025 | 874.8 |
Opportunities · 0118.5% of this theme group
Telehealth (669) · Telemedicine (567) · Pandemic (136) · Coronavirus disease 2019 (120)
Urgent and non-emergent telehealth care for seniors: Findings from a multi-site impact study
Using inpatient telehealth for family engagement: A mixed methods study of perceptions from patients, families, and care team providers
| Year | Share index |
|---|---|
| 2022 | 548.9 |
| 2023 | 380.0 |
| 2024 | 246.2 |
| 2025 | 194.7 |
Opportunities · 0216.2% of this theme group
Drug discovery (597) · Computational biology (310) · Chemical space (104) · Drug (199)
Assessing molecular docking tools: understanding drug discovery and design
Landscape of <i>In Silico</i> Tools for Modeling Covalent Modification of Proteins: A Review on Computational Covalent Drug Discovery
| Year | Share index |
|---|---|
| 2022 | 182.1 |
| 2023 | 196.4 |
| 2024 | 225.2 |
| 2025 | 259.1 |
Opportunities · 0315.8% of this theme group
Digital health (225) · Health informatics (198) · Health care (254) · Public health (106)
IDEAS (Integrate, Design, Assess, and Share): A Framework and Toolkit of Strategies for the Development of More Effective Digital Interventi
Integrated Digital Mental Health Care: A Vision for Addressing Population Mental Health Needs
| Year | Share index |
|---|---|
| 2022 | 540.1 |
| 2023 | 553.1 |
| 2024 | 540.7 |
| 2025 | 849.1 |
Opportunities · 0415.7% of this theme group
Drug discovery (269) · Drug (133) · Pharmacology (64) · In vivo (56)
Development and Characterization of Selective FAK Inhibitors and PROTACs with <i>In Vivo</i> Activity
A kinase to cytokine explorer to identify molecular regulators and potential therapeutic opportunities
| Year | Share index |
|---|---|
| 2022 | 512.3 |
| 2023 | 527.8 |
| 2024 | 495.0 |
| 2025 | 494.4 |
Opportunities · 0513.1% of this theme group
Cancer (230) · Precision medicine (278) · Oncology (89) · Breast cancer (91)
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Systems approach for congruence and selection of cancer models towards precision medicine
| Year | Share index |
|---|---|
| 2022 | 893.2 |
| 2023 | 1222.6 |
| 2024 | 953.9 |
| 2025 | 908.7 |
Opportunities · 0611.3% of this theme group
Precision medicine (299) · Personalized medicine (212) · Disease (137) · Health care (84)
Phenome-Wide Association Studies as a Tool to Advance Precision Medicine
Precision medicine in complex diseases—Molecular subgrouping for improved prediction and treatment stratification
| Year | Share index |
|---|---|
| 2022 | 1258.8 |
| 2023 | 1116.7 |
| 2024 | 1011.1 |
| 2025 | 1302.9 |
Opportunities · 079.4% of this theme group
Wearable computer (90) · Remote patient monitoring (52) · Surgical robot (38) · Robot (36)
Development of a remote therapeutic monitoring platform: applications for movement disorders
IoT-enabled health monitoring system for real time patient care: Design and evaluation
| Year | Share index |
|---|---|
| 2022 | 32.7 |
| 2023 | 34.5 |
| 2024 | 35.7 |
| 2025 | 61.7 |
Orientation shares compared with 25,000 papers in the reference sample.
| Research orientation | This field | Reference sample |
|---|---|---|
| Problem-identifying | 32.5% | 9.5% |
| Promising | 29.8% | 37.5% |
| Descriptive | 14.9% | 17.5% |
| Breakthrough | 11.9% | 26.6% |
| Cautionary | 7.3% | 4.4% |
| Comparative | 2.9% | 3.7% |
| Critical | 0.7% | 0.9% |
Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.
| Concern / example paper | Papers | Share | Raised as a problem | Worldwide share |
|---|---|---|---|---|
| Privacy & surveillanceThe future of digital health with federated learning | 1,121 | 2.85% | 599 (53.4%) | 2.66% |
| Safety & misuseImpact of Rumors and Misinformation on COVID-19 in Social Media | 72 | 0.18% | 36 (50.0%) | 0.17% |
| Bias & fairnessPrivacy Protection, Personalized Medicine, and Genetic Testing | 29 | 0.07% | 16 (55.2%) | 0.06% |
| Hardware, e-waste & supply chainToo many bits: tackling the waste epidemic in digital medicine | 4 | 0.01% | 1 (25.0%) | 0.01% |
| Concentration of compute powerDemonopolizing Medical Knowledge | 3 | 0.01% | 2 (66.7%) | 0.01% |
| Energy & datacenter footprintSUSTAINABLE GREEN COMPUTING FOR MEDICAL APPLICATIONS: ADVANCING RESPONSIBLE HEALTHCARE IT | 2 | 0.01% | 2 (100.0%) | 0.01% |
| Labour & data workLabor markets for health supply chain management in Rwanda: a qualitative study of stakeholder perspectives | 2 | 0.01% | 2 (100.0%) | 0.01% |
| Carbon & emissions of computePotential reduction in healthcare carbon footprint by autonomous artificial intelligence | 1 | 0.0% | 0 (0.0%) | 0.0% |
| Water use | 0 | 0.0% | 0 (%) | 0.0% |
Institution and researcher rankings use citations to their covered work. Research scope: United States. This may be broader than the company geography.
Compare demand signals in Los Angeles’s newsflow with the healthtech categories mapped to each signal.
Signal percentile − supply percentile = gap in percentile points. Positive gaps highlight questions to investigate. A high signal can reflect spending pressure or access friction, as well as potential demand.
The comparison is relative to the signal families on this page. A supply percentile of zero means the lowest relative reading, not zero companies. It is a prioritisation clue, not measured market size or unmet demand.
Signal and mapped-supply percentiles, their gap, and change in the signal’s article share.
Swipe horizontally to compare all columns →
| Signal family | Signal percentile | Supply percentile | Relative gap | Gap (points) | Signal share vs prior year |
|---|---|---|---|---|---|
| Mental health ↗Disease Burden | 100.0 | 50.0 | +50.0 | +127.9% | |
| Ageing & elder care ↗Disease Burden | 50.0 | 0.0 | +50.0 | +41.0% | |
| Cancer burden ↗Disease Burden | 10.0 | 100.0 | -90.0 | +1.7% | |
| Air pollution ↗Environmental Driver | 50.0 | — | No matching category | — | +1.8% |
| Maternal & child health ↗Disease Burden | 40.0 | — | No matching category | — | +70.7% |
| Layoffs & income shocks ↗Spending Pressure | 50.0 | — | No matching category | — | +7.2% |
Showing all 6 signals. Select a family for its history and mapped categories.
All 12 city readings for these demand families in the comparison geography. Los Angeles is highlighted.
Each city’s reading is a share of its own coverage. Rows cover all of the United States for this page's signal families; Los Angeles is marked.
Layoffs & income shocks · Mental health · Maternal & child health
Layoffs & income shocks · Maternal & child health · Cancer burden
Layoffs & income shocks · Mental health · Maternal & child health
Layoffs & income shocks · Maternal & child health · Air pollution
Maternal & child health · Mental health · Air pollution
Maternal & child health · Layoffs & income shocks · Mental health
Layoffs & income shocks · Air pollution · Mental health
Maternal & child health · Mental health · Layoffs & income shocks
Mental health · Maternal & child health · Layoffs & income shocks
Mental health · Air pollution · Layoffs & income shocks
Maternal & child health · Cancer burden · Mental health
Layoffs & income shocks · Maternal & child health · Mental health
Mental-health pressure can pull counselling and tele-psychiatry demand where it surfaces.
Companies can appear in multiple categories; these counts are not a unique-company total.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 43 | 13.0 |
| 2024Q4 | 29 | 8.38 |
| 2025Q1 | 236 | 32.12 |
| 2025Q2 | 23 | 6.69 |
| 2025Q3 | 49 | 13.4 |
| 2025Q4 | 36 | 14.99 |
| 2026Q1 | 427 | 148.36 |
An ageing base can shift demand toward geriatric, home and chronic care.
Companies can appear in multiple categories; these counts are not a unique-company total.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 16 | 4.84 |
| 2024Q4 | 24 | 6.94 |
| 2025Q1 | 24 | 3.27 |
| 2025Q2 | 24 | 6.98 |
| 2025Q3 | 24 | 6.56 |
| 2025Q4 | 23 | 9.58 |
| 2026Q1 | 16 | 5.56 |
Cancer burden can pull screening, diagnostics and oncology capacity demand.
Companies can appear in multiple categories; these counts are not a unique-company total.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 18 | 5.44 |
| 2024Q4 | 28 | 8.09 |
| 2025Q1 | 25 | 3.4 |
| 2025Q2 | 16 | 4.65 |
| 2025Q3 | 11 | 3.01 |
| 2025Q4 | 7 | 2.91 |
| 2026Q1 | 40 | 13.9 |
Sustained air-quality stress can pull respiratory and cardiac care demand with it.
This signal has no matching category in the page’s healthtech market map, so no supply percentile or gap is assigned.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 25 | 7.56 |
| 2024Q4 | 27 | 7.8 |
| 2025Q1 | 81 | 11.02 |
| 2025Q2 | 39 | 11.34 |
| 2025Q3 | 39 | 10.67 |
| 2025Q4 | 20 | 8.33 |
| 2026Q1 | 19 | 6.6 |
Maternal and child burden can pull immunisation, nutrition and pediatric care demand.
This signal has no matching category in the page’s healthtech market map, so no supply percentile or gap is assigned.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 6 | 1.81 |
| 2024Q4 | 5 | 1.45 |
| 2025Q1 | 19 | 2.59 |
| 2025Q2 | 18 | 5.23 |
| 2025Q3 | 28 | 7.66 |
| 2025Q4 | 7 | 2.91 |
| 2026Q1 | 14 | 4.86 |
Layoff cycles can pull discretionary spend back toward value offerings.
This signal has no matching category in the page’s healthtech market map, so no supply percentile or gap is assigned.
Mentions per 10,000 articles · zero baseline
| Quarter | Mentions | Per 10,000 articles |
|---|---|---|
| 2024Q3 | 20 | 6.05 |
| 2024Q4 | 39 | 11.27 |
| 2025Q1 | 67 | 9.12 |
| 2025Q2 | 28 | 8.14 |
| 2025Q3 | 50 | 13.67 |
| 2025Q4 | 8 | 3.33 |
| 2026Q1 | 24 | 8.34 |
Los Angeles healthtech coverage
MMWR Morbidity and Mortality Weekly Report
273 citations in the snapshot
Ear and Hearing
135 citations in the snapshot
JAMA Internal Medicine
133 citations in the snapshot
MMWR Morbidity and Mortality Weekly Report
129 citations in the snapshot
Los Angeles coverage of this page's demand families
| Keyword | Recent articles | Prior articles | Share change |
|---|---|---|---|
| hospice cancer | 27 | 15 | 156.8% |
| smog reduction | 24 | 17 | 101.4% |
| clean air advocacy | 44 | 44 | 42.7% |
| emissions controls | 24 | 25 | 37.0% |
| pollution control statutes | 22 | 23 | 36.5% |
Share changes describe coverage in the stated comparison periods, not search demand or market size.
Clear definitions for making better comparisons.
It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.
No. A company can belong to several segments, so segment counts and funding can overlap.
A dash or unavailable panel means the current reviewed source snapshot does not support that figure.
Company ecosystem snapshot: 5 August 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.
Canonical landscape ↗